A novel four-protein biomarker blood panel promotes early pancreatic cancer detection, identifying 91.9% of cancer cases and surpassing standard tests.
Recent research is highlighting different approaches that may better predict diabetes risk than current methods.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results